Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Colorectal Neoplasms × Bevacizumab × Clear all

Status

Completed 158 Recruiting 59 Unknown 47 Terminated 47 Not yet recruiting 27 Active not recruiting 26 Withdrawn 15 Suspended 2 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

regorafenib 1 pegilodecakin 1 onvansertib 1 IFL protocol 1 HMPL-013 1 Bevacizumab 1 AM0010 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04446793 2024-02-12

Expanded Access of Onvansertib With FOLFIRI and Bevacizumab for the Second-Line Treatment of Participants With KRAS-Mutated Metastatic Colorectal Cancer

Cardiff Oncology

No longer available

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡